Intravenous Beta-Blockade in Coronary Heart Disease
- 18 March 1982
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 306 (11) , 631-635
- https://doi.org/10.1056/nejm198203183061102
Abstract
Beta-blocking drugs are increasingly prescribed in coronary heart disease, but controversy surrounds the hemodynamic relevance of their ancillary pharmacologic properties — cardioselectivity and intrinsic sympathomimetic activity. We therefore compared the effects of four intravenous beta-adrenoreceptor antagonists with different ancillary properties on left ventricular function in 24 patients with coronary heart disease.Keywords
This publication has 30 references indexed in Scilit:
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1980
- EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1979
- Comparison of the Immediate Effects of Five β-Adrenoreceptor-Blocking Drugs with Different Ancillary Properties in Angina PectorisNew England Journal of Medicine, 1979
- PROTECTIVE EFFECT OF PROPRANOLOL IN THREATENED MYOCARDIAL INFARCTIONThe Lancet, 1978
- Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.BMJ, 1977
- Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.BMJ, 1975
- REDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTIONThe Lancet, 1974
- REDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTION BY TREATMENT WITH ALPRENOLOL: Preliminary ResultsPublished by Elsevier ,1974
- ??-Adrenergic Receptor Blocking Drugs in Cardiac Arrhythmias1Drugs, 1974